JP2022523679A5 - - Google Patents
Info
- Publication number
- JP2022523679A5 JP2022523679A5 JP2021543205A JP2021543205A JP2022523679A5 JP 2022523679 A5 JP2022523679 A5 JP 2022523679A5 JP 2021543205 A JP2021543205 A JP 2021543205A JP 2021543205 A JP2021543205 A JP 2021543205A JP 2022523679 A5 JP2022523679 A5 JP 2022523679A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- vector
- composition according
- composition
- aav vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797495P | 2019-01-28 | 2019-01-28 | |
| US62/797,495 | 2019-01-28 | ||
| US201962914682P | 2019-10-14 | 2019-10-14 | |
| US62/914,682 | 2019-10-14 | ||
| PCT/US2020/015386 WO2020159970A1 (en) | 2019-01-28 | 2020-01-28 | Compositions and methods for evading humoral immunity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523679A JP2022523679A (ja) | 2022-04-26 |
| JP2022523679A5 true JP2022523679A5 (enExample) | 2023-02-03 |
| JP7707066B2 JP7707066B2 (ja) | 2025-07-14 |
Family
ID=71840382
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543205A Active JP7707066B2 (ja) | 2019-01-28 | 2020-01-28 | 体液性免疫を回避する組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220143213A1 (enExample) |
| EP (1) | EP3894571A4 (enExample) |
| JP (1) | JP7707066B2 (enExample) |
| KR (1) | KR20210126029A (enExample) |
| CN (1) | CN113544278A (enExample) |
| AU (1) | AU2020215682B2 (enExample) |
| CA (1) | CA3127950A1 (enExample) |
| WO (1) | WO2020159970A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021067598A1 (en) | 2019-10-04 | 2021-04-08 | Ultragenyx Pharmaceutical Inc. | Methods for improved therapeutic use of recombinant aav |
| BR112022011916A2 (pt) | 2019-12-19 | 2022-09-06 | Univ Pennsylvania | Composições para tratar a ataxia de friedreich |
| EP4096691A1 (en) | 2020-01-28 | 2022-12-07 | Freeline Therapeutics Limited | Improved assay for determining neutralising antibody titre to a viral vektor |
| AU2021218703A1 (en) | 2020-02-14 | 2022-07-28 | Ultragenyx Pharmaceutical Inc. | Gene therapy for treating CDKL5 deficiency disorder |
| GB202007431D0 (en) | 2020-05-19 | 2020-07-01 | Hansa Biopharma AB | Cysteine protease |
| EP4274592A4 (en) * | 2021-01-11 | 2025-03-19 | The Trustees of The University of Pennsylvania | COMPOSITIONS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA |
| JP2024531138A (ja) | 2021-08-11 | 2024-08-29 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | 筋ジストロフィーを処置するための組成物および方法 |
| CN117801116A (zh) * | 2022-09-30 | 2024-04-02 | 上海玮美基因科技有限责任公司 | 一种融合型新型腺相关病毒及其应用 |
| WO2025047848A1 (ja) | 2023-08-30 | 2025-03-06 | アステラス製薬株式会社 | ＩｄｅＺ改変体 |
| WO2025245490A1 (en) * | 2024-05-23 | 2025-11-27 | Duke University | Compositions comprising antibody cleaving enzymes and methods of use thereof |
| CN118497176B (zh) * | 2024-07-16 | 2025-01-21 | 苏州康聚生物科技有限公司 | 一种免疫球蛋白降解酶 |
| WO2026041758A1 (en) * | 2024-08-22 | 2026-02-26 | Genethon | Modified aav capsid with enhanced transduction efficiency |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009535339A (ja) * | 2006-04-28 | 2009-10-01 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 低下されたキャプシド免疫原性を有する改変ａａｖベクターおよびその使用 |
| GB201502305D0 (en) * | 2015-02-12 | 2015-04-01 | Hansa Medical Ab | Protein |
| US20210228738A1 (en) | 2017-07-17 | 2021-07-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins |
-
2020
- 2020-01-28 CN CN202080019766.8A patent/CN113544278A/zh active Pending
- 2020-01-28 JP JP2021543205A patent/JP7707066B2/ja active Active
- 2020-01-28 KR KR1020217027264A patent/KR20210126029A/ko not_active Ceased
- 2020-01-28 US US17/425,765 patent/US20220143213A1/en active Pending
- 2020-01-28 AU AU2020215682A patent/AU2020215682B2/en active Active
- 2020-01-28 EP EP20749331.3A patent/EP3894571A4/en active Pending
- 2020-01-28 CA CA3127950A patent/CA3127950A1/en active Pending
- 2020-01-28 WO PCT/US2020/015386 patent/WO2020159970A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111902539B (zh) | 杂合调控元件 | |
| JP7707066B2 (ja) | 体液性免疫を回避する組成物および方法 | |
| JP2022033855A5 (enExample) | ||
| JP2022508182A5 (enExample) | ||
| IL299325B2 (en) | Acid-alpha glucosidase variants and uses thereof | |
| JP2020048571A5 (enExample) | ||
| JP2022547197A5 (enExample) | ||
| US20160355573A1 (en) | Gene therapy for alzheimer's and other neurodegenerative diseases and conditions | |
| TW202005978A (zh) | 新穎肝靶向腺相關病毒載體 | |
| JP2021513999A5 (enExample) | ||
| JP2019501115A (ja) | 遺伝子治療のためのアデノ随伴ウイルスベクターのくも膜下腔内投与 | |
| JP2021512649A5 (enExample) | ||
| JP2021533805A5 (enExample) | ||
| JP2023088902A5 (enExample) | ||
| JP2022541070A5 (enExample) | ||
| JP2023535620A5 (enExample) | ||
| JP2021520811A5 (enExample) | ||
| JP2022551744A5 (enExample) | ||
| US20210292724A1 (en) | Mini-gde for the treatment of glycogen storage disease iii | |
| JP2024517843A5 (enExample) | ||
| JP2023065516A5 (enExample) | ||
| JP2024515626A5 (enExample) | ||
| CN117897492A (zh) | 用于肌肉和cns中的基因表达的杂合启动子 | |
| JP2025515356A5 (enExample) | ||
| JP2023504201A5 (enExample) |